JAMA's editor Catherine DeAngelis writes an editorial " The Influence of Money on Medical Science":
Now comes the potential problem. In some instances, the marketing goal of a company dominates the scientific aspect of the company-funded research. There have been a number of high-profile examples of such research irregularities involving for-profit companies, such as the refusal to provide all study data to the study team,2 reporting only 6 months of data in a trial designed to have 12 months of data as the primary outcome3; incomplete reporting of serious adverse events4-5; and concealing clinical trial data showing harm.6
Once again, she is the Queen of Quotes:
the degree I hold is an MD, not an MDeity; I have no ability to know what is in the minds, hearts, or souls of authors. Furthermore, I do not have, nor desire to have, the resources of law enforcement agencies, but I do know that the accuracy of lie detector tests is questionable.
Source.
No comments:
Post a Comment